Introduced by international experts and NordiQC specialists, the conference is focused on development and standardization of IHC and related molecular based techniques for tumor classification and precision medicine.
Issues of IHC protocol optimization, selection and interpretation of positive and negative controls, and external quality assessment (EQA) / proficiency testing will be highlighted. Special emphasis is given on up-to-date pathological approach to new diagnostic and predictive biomarkers, particularly in tumors of breast, lung, digestive system, kidney, urinary tract, prostate, testis and soft tissues.
Horizon hosted a talk at NordiQC:
Tuesday 6th June
17:10 - 17:30
Enabling PD-L1 IHC standardization using defined reference standards and digital pathology